Bayer known for its perfectness in development of Pharmaceutical products, has decided to do collabortion with Digital Healthcare Start-Ups world wide.
Bayer shifted its focus on following area
- Digital therapeutics
- Aartificial Intelligance (AI) for drug discovery
- Patient Engagement Platforms
To do this, Bayer created G4A programs in 2013 and now a days concentrating on longer-term collaborations and investments new start ups for heatcare segment.
About G4A Programme:
This programme was started by bayer to augment digital innovation in healthcare segment.Till date 149 companies got support from bayer under G4A Programme. Which resulted in 29 direct collaborations with following companies.
Start-ups will be given one-time initial funding (EUR 50,000 to EUR 100,000),further if they reached on jointly defined milestones will also receive additional payments from Bayer.